Spyre Therapeutics, Inc.: Form 8-K/A, filed Aug 8, 2024
Filed with the SEC on Aug 8, 2024 and accepted by EDGAR at Aug 7, 2024, 22:53 ET.
Items reported
- Item 8.01 Other events
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Source: SEC EDGAR, the filing index for accession 0001636282-24-000058. Last ingested by Listed: Oct 24, 2026, 15:14 ET. Listed shows no prices and gives no investment advice.